Apoptotic profiling of chronic myeloid leukaemia patients' platelets ex vivo before and after treatment with Imatinib

Author(s):  
Lisa Repsold ◽  
Roger Pool ◽  
Mohammed Karodia ◽  
Gregory Tintinger ◽  
Piet Becker ◽  
...  
2012 ◽  
Vol 61 ◽  
pp. 66-77 ◽  
Author(s):  
Chi Yip Joan Ma ◽  
Nicki Panoskaltsis ◽  
Robin Kumar ◽  
Xiao Yun Xu ◽  
Athanasios Mantalaris

1989 ◽  
Vol 82 (4) ◽  
pp. 205-209 ◽  
Author(s):  
L.M. Secker-Walker ◽  
H.M. Cooke ◽  
P.J. Browett ◽  
J.D. Norton ◽  
C. Kitchen ◽  
...  

1998 ◽  
Vol 32 (1-2) ◽  
pp. 151-157 ◽  
Author(s):  
FranÇOis-Xavier Mahon ◽  
ValÉRie Pigeonnier-Lagarde ◽  
Hikmat Chahine ◽  
VÉRonique Maguer-Satta ◽  
Jean Ripoche ◽  
...  

1997 ◽  
Vol 98 (2) ◽  
pp. 467-473 ◽  
Author(s):  
FranÇois‐Xavier Mahon ◽  
Valérie Pigeonnier‐Lagarde ◽  
Hikmat Chahine ◽  
Caroline Barbot ◽  
Bozena Jazwiec ◽  
...  

1934 ◽  
Vol 34 (1) ◽  
pp. 99-117 ◽  
Author(s):  
Leonard S. Dudgeon ◽  
L. T. Bond

1. Eighty-seven specimens of septic pus obtained from patients suffering from recent and old infections were examined fully bacteriologically and cytologically and were sterilised at 60° C. for 2 or 4 hours. The heated samples of pus were used for our experiments.2. Glycerine extracts were prepared of the pus by two methods referred to in detail in the text.3. The digestive action of the samples of sterile pus and of their glycerine extracts were tested on inspissated blood serum, gelatin, milk, egg and hydrocele saline. Digestion occurred on all these media in varying degrees with the specimens of pus, but glycerine extracts were more active.4. It was found that the addition of pus or glycerine extracts of pus with various strains of Bacillus typhosus, B. paratyphosus A, B and C, B. gaertner and B. shiga to milk, produced clotting of the medium at 37° C. in the majority of our experiments.5. If pus was heated at 60° C. for as long as 6 hours its digestive manifestations were not affected, but 80° C. for 20 min. or 100° C. for 10 min. completely destroyed the digestive activity.6. At 22° C. the digestive action of pus was weakly manifested, while in the ice chest no reaction whatever took place.7. Clotting of the medium occurred when pus was added to killed growths of B. typhosus and B. paratyphosus A in milk, but not with B. paratyphosus B or B. gaertner.8. Human milk did not clot with pus and these organisms.9. A large number of observations were made with serum exudates from pus, either after filtering through a Seitz E.K. filter or after heating at 60° C. It was found that the filtered or heated fluids might have a similar or a weaker action as compared with pus, or they might be inhibitory.10. The white cells from several cases of chronic myeloid leukaemia, chronic lymphatic, the myeloblastic termination of chronic myeloid and acute leukaemia, were examined in the same manner as pus. The cells of chronic myeloid leukaemia acted in every way like pus, those of chronic lymphatic and their glycerine extracts were quite inactive; those of acute leukaemia corresponded to chronic lymphatic, while those of a myeloblastic termination gave a weak digestive reaction.11. Specimens of blood serum from normal human beings and from patients with acute infections, and some specimens of body fluids before and after filtering, were found to inhibit the clotting of milk inoculated with pus and the microbes.12. Twenty-two specimens of tuberculous pus obtained from abscesses and from pyo-pneumothorax, and seven samples of tuberculous sputum, were examined fully, but with special reference to their cytology.In eight cases the pus showed no digestive action and no clotting of milk with the microbes, in nine cases a feeble reaction occurred, and in five cases the reactions were like those of pyogenic pus. Thus seventeen of the specimens could bedistinguished readily from pyogenic pus; in the five positive specimens polymorphs were numerous, but one of these cases was complicated by a secondary infection. In every sample of tuberculous sputum polymorphs and tubercle bacilli were numerous and the reactions corresponded to those of pyogenic pus.


1992 ◽  
Vol 68 (05) ◽  
pp. 500-505 ◽  
Author(s):  
Ch M Samama ◽  
Ph Bonnin ◽  
M Bonneau ◽  
G Pignaud ◽  
E Mazoyer ◽  
...  

SummaryWe investigated the comparative antithrombotic properties of clopidogrel, an analogue of ticlopidine, and aspirin, using the Folts' model on femoral arteries in 22 pigs. On each animal, clopidogrel or aspirin were used to treat the thrombotic process on the left femoral artery and to prevent this process on the right femoral artery. Sequentially: an injury and stenosis were carried out on the left femoral artery; the thrombotic process was monitored with a Doppler during a 30-min observation period for cyclic flow reductions or permanent cessation of flow; after the first cyclic flow reduction occurred, clopidogrel (5 mg kg-1) or aspirin (2.5, 5, 100 mg kg-1) were injected intravenously; if cyclic flow reductions were abolished, epinephrine (0.4 µg kg-1 min-1) was injected to try to restore cyclic flow reductions and/or permanent cessation of flow; then injury and stenosis were applied on the right femoral artery. Before and after injection of clopidogrel or aspirin, ear immersion bleeding times and ex-vivo platelet aggregation were performed. Clopidogrel (n = 7) abolished cyclic flow reductions in all animals and epinephrine did not restore any cyclic flow reduction. On the right femoral artery, cyclic flow reductions were efficiently prevented, even for two injuries. Basal bleeding time (5 min 28) was lengthened (>15 min, 30 min after clopidogrel and remained prolonged even after 24 h). ADP-induced platelet aggregation was inhibited (more than 78%). Comparatively, aspirin had a moderate and no dose-dependent effect. Aspirin 2.5 mg kg-1 (n = 6) abolished cyclic flow reductions in 2 animals, CFR reoccurred spontaneously in one animal and epinephrine restored it in a second animal. Aspirin 5 mg kg-1 (n = 6) abolished cyclic flow reductions in only 3 animals and epinephrine always restored it. Aspirin 100 mg kg-1 (n = 3) was unable to abolish cyclic flow reductions. On the right femoral artery, aspirin did not significantly prevent cyclic flow reductions which occurred in all animals after one (n = 14) or two injuries (n = 1), except for one animal. Basal bleeding time was lengthened but it shortened rapidly, reaching its basal value after 24 h. ADP-induced aggregation was not significantly inhibited, whereas arachidonic acid induced aggregation was always inhibited. Clopidogrel appears as a more potent antithrombotic drug than aspirin in this model, in treating and preventing spontaneous or epinephrine-induced cyclic flow reductions and lengthening bleeding time.


1991 ◽  
Vol 65 (05) ◽  
pp. 504-510 ◽  
Author(s):  
Raffaele De Caterina ◽  
Rosa Sicari ◽  
Walter Bernini ◽  
Guido Lazzerini ◽  
Giuliana Buti Strata ◽  
...  

SummaryTiclopidine (T) and aspirin (ASA) are two antiplatelet drugs both capable of prolonging bleeding time (BT), with a different mechanism of action. A synergism in BT prolongation has been reported and is currently considered an argument for not recommending their combination. However, a profound suppression of platelet function might be a desirable counterpart of a marked prolongation of BT, with a possible use in selected clinical situations. We therefore studied ex vivo platelet function (aggregation by ADP 0.5-1-2.5 μM; adrenaline 0.75-2.5 μM; collagen 1.5-150 μg/ml; arachidonic acid 1 mM; PAF 1 μM; adrenaline 0.17 μM + ADP 0.62 μM; serum thromboxane ([TX]B2 generation) and BT (Mielke) in 6 patients with stable coronary artery disease receiving such combination. Patients underwent sequential laboratory evaluations at baseline, after 7 days of T 250 mg b.i.d., before and after the intravenous administration of ASA 500 mg, respectively, and, finally, after a minimum of 7 days of sole ASA oral administration (50 mg/day). The experimental design, therefore, allowed a comparison of T and ASA effects (2nd and 4th evaluation), and an assessment of the combination effect (3rd evaluation). Platelet aggregation in response to all doses of ADP was depressed more by T than by ASA. Conversely, responses to adrenaline, and arachidonate were affected more by ASA than by T. For all other agents, differences were not significant. T + ASA combination was more effective (p <0.05) than either treatment alone in depressing responses to high-dose collagen (% over control, mean ± SEM: T: 95 ± 3; ASA: 96 ± 5; T + ASA: 89 ± 4). Serum TXB2 (basal, ng/ml: 380 ± 54) did not change with T (372 ± 36), dropped to <1 ng/ml on ASA injection and slightly re-increased to 9.1 ± 3.1 ng/ml on oral low-dose ASA. BT (basal 7.4 ± 0.6 min) was affected similarly by T (9.2 ± 0.8) or ASA (9.7 ± 0.9) alone, but increased to 15.0 ± 0.7 min on combination treatment (106% increase over control). Thus, the strong synergism in BT prolongation by ASA-T combination has a counterpart in the inhibition of platelet function in response to strong stimuli such as high-dose collagen, not otherwise affected significantly by single-drug treatment. This effect is a possible rationale for the clinical evaluation of T + ASA combination.


Sign in / Sign up

Export Citation Format

Share Document